M.D. Anderson's C. Stratton Hill Receives Award From American Cancer Society

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 23 No 5
Volume 23
Issue 5

CHICAGO--The American Cancer Society has presented its Humanitarian Award to C. Stratton Hill, Jr., MD, of the University of Texas M.D. Anderson Cancer Center. The award is given for dedication to thea improvement of cancer control and genuine accomplishment in human welfare.

CHICAGO--The American Cancer Society has presented its HumanitarianAward to C. Stratton Hill, Jr., MD, of the University of TexasM.D. Anderson Cancer Center. The award is given for dedicationto thea improvement of cancer control and genuine accomplishmentin human welfare.

As an oncologic endocrinologist, and later as associate directorof clinics at M.D. Anderson, Dr. Hill helped lay the foundationfor what has become the largest oncologic clinic in the world.As director of the Pain Service at M.D. Anderson, Dr. Hill hasworked to improve the state of pain control and has earned aninternational reputation as a leader in this field, working withstate legislatures and pharmacy and narcotic boards.

Articles in this issue
Earlier Unrelated BMT Is Effective in CML Subgroup
Taxol/Cisplatin Extends Survival in Advanced Ovarian Ca
Prostate Cancer Patients Face a Host of Psychosocial Issues
NSABP to Study Docetaxel in Operable Breast Cancer
Panel Recommends Approval of Talc for Malignant Pleural Effusions
ODAC Recommends Approval of Verluma for Staging of SCLC
Minorities Lack Internet Access to Cancer Research Data
Fludarabine Produces CRs as First-Line CLL Therapy
M.D. Anderson's C. Stratton Hill Receives Award From American Cancer Society
Managed Care: The View From Salick Managed Care
Selling 'High Risk' Part of an Oncology Practice Can Increase Financial Stability
Entries Are Sought for Kushner Writing Award
Docetaxel Effective as First-Line Breast Cancer Therapy
Roswell Park Institute Establishes Hepatic Cryosurgery Center
High-Dose RAIT May Improve Prognosis in Relapsed NHL Patients

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
A paucity of prospective, well-vetted data to guide therapy in patients with rare lymphomas may result in a reliance on expert consensus guidelines.
Related Content
Multivariate analysis showed consolidative thoracic radiotherapy improved OS/PFS vs control patients with ES-SCLC, with respective HRs of 0.53 and 0.90.

Consolidative Thoracic Radiotherapy Improves Survival in ES-SCLC

Roman Fabbricatore
April 18th 2025
Article

Multivariate analysis showed consolidative thoracic radiotherapy improved OS/PFS vs control patients with ES-SCLC, with respective HRs of 0.53 and 0.90.

Fostering the Future of Psychosocial Care With World Psycho-Oncology Day

Fostering the Future of Psychosocial Care With World Psycho-Oncology Day

Cristiane Decat Bergerot, PhD
April 14th 2025
Podcast

Integrating psychosocial care into cancer care allows patients to receive emotional support, counseling, and coping strategies to help navigate treatment.

Patients with painful lesions who did not undergo treatment with opioids or reirradiation generally had better outcomes than those who did.

Classification System May Identify QOL Benefit with Palliative Radiotherapy

Roman Fabbricatore
April 18th 2025
Article

Patients with painful lesions who did not undergo treatment with opioids or reirradiation generally had better outcomes than those who did.

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Elevating the Quality of Cancer Care via Cross-Department Collaboration

Rachit Kumar, MD;Michael J. Pishvaian, MD, PhD;Nina D. Wagner-Johnston, MD;Valerie Lee, MD;Armine K. Smith, MD;Pouneh Razavi, MD;Curtiland Deville Jr., MD
April 7th 2025
Podcast

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Optimizing Radiosurgery for CNS Tumors, Insights on Technology and Teamwork

Optimizing Radiosurgery for CNS Tumors, Insights on Technology and Teamwork

Ariana Pelosci
April 18th 2025
Article

William Kennedy, MD, discussed modern radiosurgery techniques, technology selection, and the multidisciplinary approach for treating complex CNS tumors.

Taletrectinib Yields Durable Responses, Prolonged PFS in ROS1+ NSCLC

Taletrectinib Yields Durable Responses, Prolonged PFS in ROS1+ NSCLC

Tim Cortese
April 18th 2025
Article

Pooled results from the TRUST-I and TRUST-II trials showed that taletrectinib led to infrequent neurological TEAEs in patients with ROS1-positive NSCLC.